LALPATHLAB — Dr. Lal PathLabs Share News
0.000.00%
Last trade - 00:00- IN₹311.00bn
- IN₹299.44bn
- IN₹27.63bn
India's Dr Lal PathLabs rises as Axis Securities initiates with 'buy'
India's Dr Lal PathLabs rises; analysts back SN Genelab deal
Brief: Lal Pathlabs Says Subsidiary Incorporated Dr Lal Pathlabs Indomed In Tashkent, Uzbekistan
India's Dr Lal PathLabs jumps to 4-year high after quarterly profit rise
India's Dr Lal PathLabs posts higher first-quarter profit on healthy demand for tests
Brief: Lal Pathlabs Receives Appellate Order From Tax Department Allowing Appeal
India's Lal PathLabs set for best day ever after quarterly results
India's Dr Lal Path Labs posts quarterly profit fall on tax expense
Brief: Lal Pathlabs To Buy 100% Stake In Shahbazkers Diagnostic Centre
Brief: Lal Pathlabs March-Quarter Consol Net Profit 1.31 Billion Rupees
Citi turns bullish on India's Dr Lal PathLabs, upgrades to buy
Dr. Lal Path Labs posts earnings dip on Indian labour code changes; test demand strong
Brief: Dr. Lal Pathlabs Q3 Consol Net Profit 905 Million Rupees
India's Dr Lal Path Labs climbs on Q2 profit rise
India's Dr Lal Path Labs gains on considering issue of bonus shares
Brief: Lal Pathlabs To Consider Issuance Of Bonus Shares
Metropolis Healthcare rises on higher quarterly revenue
India-focused pharma firms' margins to improve from GST cuts, CLSA says
Brief: Dr. Lal Pathlabs Expands Genomics Capabilities With Illumina's Novaseq X Series